IMBiotechnologies is a privately held Canadian biotechnology company whose focus is commercializing medical device products in the area of embolotherapy. IMBiotechnologies' lead product is Ekobi 500 Embolization Microspheres. It is a first in class biodegradable embolic agent that is visible by ultrasound. Ekobi 500 is a medical device cleared by the FDA for the treatment of hypervascularized tumors.